↑
Jump to Content
The online international conference was held on January 31, 2024. The conference discussed the measures required in Israel and other countries to combat malignant tumors caused by the human papillomavirus, following the initiative of the World Health Organization which calls for increased vaccination against the virus, screening, and targeted treatment. Currently, the virus causes about 600,000 cases of cervical cancer worldwide, as well as oral and throat cancer, particularly affecting men. The online conference also served as a tool to express support for the Israeli medical community during this difficult time. Approximately 250 doctors, both from Israel and the international community, participated in the conference. The Israeli scientific societies participating in this event include: Israel Society for the Study and Prevention of STI (ISSSTI) Israel Society of Colposcopy and Cervical Pathology (ISCCP) Israel Society of Gynecological Oncologists (ISGP) The Israeli National Academy of Medical Sciences The Israeli Medical Association (IMA)
PDF Flyer
Webinar Organizers:
Cervical glandular lesion management is a challenge for clinicians from screening to diagnosis and treatment. This webinar will discuss the contents from screening to colposcopy, pathology and treatment.
Objectives:
Participants will learn the difficulties of cervical glandular lesions in cytology and histology, the management of AGC, the colposcopy image of AIS, and the management AIS.
Program:
Faculty:
Chengquan Zhao, MD; Professor of gynecological/breast pathology and cytological director of Magee Womens Hosptial, University of Pittsburgh Dr. Zhao received Medicine degree from Qingdao Medical College, China, completed four years residency training in Pathology at Drexel University, one year fellow training in Gynecologic/Breast Pathology at AFIP, and one year fellow training in Cytopathology at the University of Southern California. He joined the faculty of the Department of Pathology, Magee Women Hospital in July 2006 and promoted as full professor at 2012. His research interests are focused on the areas of cervical cancer screening, correlation of Pap test and HPV test. He has published 230 papers and 160 abstracts.
Long Sui, MD, PhD; Obstetrics & Gynecology Hospital, Fudan University; Professor and Chief Physician for Gynecology, Gynecologic Oncology, Colposcopy and Gynecologic Endoscopy Prof and Dr. Long Sui is an expert of the Committee on Continuing Education and Training, IFCPC and Vice chairman of both the Chinese Society of Colposcopy and Cervical Pathology, CSCCP and the Chinese Obstetrics And Gynecology Association Colposcopy and Cervical Neoplasia Committee, COGA-CCNC. He has led or participated in the drafting of several practice guidelines or expert consensus on the prevention and treatment of CIN, VaIN, VIN, AIN and HPV vaccine in China. He has hosted 14 research projects funded by the National Natural Science Foundation and et al and published over 160 papers in peer reviewed core journals. Achieved 4 scientific and technological progress awards.
Yun Zhao, MD, PhD; Peking University People’s Hospital Dr ZHAO Yun is a staff physician in the department of Obstetrics/Gynecology at Peking University People’s Hospital. She got MD from Chinese PLA Postgraduate Medical School in 1999. She got Ph.D from Peking University Health Science Center in 2002. Dr. ZHAO specializes in the prevention, diagnosis and treatment of lower genital tract disease. Her clinical interests include cytology, colposcopy and precancer treatment. In 2012, she came to USA as oversea visitor, work in the Pathology and Laboratory Medicine Institute, Department of Anatomy Pathology, and in the Obgyn and Women’s Health Institute, Department of Gynecology. Cleveland Clinic. She has been working in Department of Obstetrics/Gynecology for more than 30 years.
Chair:
Jean-Luc Mergui, MD; France President, The International Federation of Cervical Pathology and Colposcopy (IFCPC)
Registration:
Notes:
Human papillomavirus (HPV) is one of the most common viral etiologies of sexually transmitted genital infections in sexually active women. In the genital area during pregnancy, genital warts or low- and high-grade intraepithelial lesions occur, as well as a lower incidence of malignant neoplasia. Diseases associated with HPV infection during pregnancy should be documented and treated according to guidelines and evidence, when detected, to reduce the risk of transmission to the newborn.
Janeth Márquez Acosta
Elsa Díaz López
Guillermo Moreno
Janeth Márquez Acosta, MD, OBGYN, MHA Dr. Janeth is a respected Professor of Obstetrics & Gynecology at the Faculty of Medicine, UNAM, and a dedicated practitioner at the High Specialty Medical Unit “Luis Castelazo Ayala Hospital” under the Mexican Social Security Institute. She specializes in colposcopy within the Department of Colposcopy and is an esteemed member of COMEGIC (Mexican college of gynecologists dedicated to colposcopy).
Elsa Díaz López, MD, MBE Dr. Elsa Diaz Lopez is an accomplished Obstetrician and Gynecologist with a Master's in Bioethics and teaching techniques in health sciences. She serves as the 1st Secretary of COMEGO (Mexican College of Obstetrics and Gynecology) and Secretary General of IFCPC (International Federation of Cervical Pathology and Colposcopy). Her extensive research includes publications on HPV vaccination in vulnerable populations, contributions to the Mexican Cancer Consensus, and guidelines for adult vaccinations.
Guillermo Moreno Flores, MD, MSc Dr. Guillermo is a highly qualified specialist in Gynecology and Obstetrics, having trained at the National Institute of Perinatology in Mexico. He holds certifications in colposcopy, laparoscopy, and an advanced specialty in breast cancer diagnosis and treatment. With a subspecialty in Gynecologic Oncology from the National Cancer Institute, Mexico, and a Master's degree in medical sciences, Dr. Guillermo has contributed to numerous national and international publications in indexed journals. He is also an active member of prestigious organizations like ESGO, IGCS, IFCPC, and COMEGIC.
International Federation for Cancer Prevention and Colposcopy 3416 Primm Lane Birmingham, Alabama, 35216 USA P: +001-205-823-6106 E: info@ifcpc.org
Jump to Content